+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Tocotrienol Market by Form, by Application, by End-User, Forecasts to 2027

  • PDF Icon

    Report

  • 160 Pages
  • August 2020
  • Region: Global
  • Reports and Data
  • ID: 5396906
Increasing use of tocotrienol for making various medicines in the pharmaceutical industry due to its health benefits such as lowering triglyceride and anticancer properties is a key factor driving market revenue growth.

Market Size - USD 369.1 Million in 2020, Market Growth - CAGR of 6.5%, Market Trends - Rising investments to extensively study properties of tocotrienol such as anti-diabetic, anti-hyperlipidemic, anticancer, anti-inflammatory, and immune-supportive by major players globally.

The global tocotrienol market size is expected to reach USD 614.9 Million in 2028, and register a CAGR of 6.5% during the forecast period. Rising prevalence of various chronic diseases and disorders, coupled with increasing awareness about uses of tocotrienol to treat breast cancer, Chronic Kidney Disease (CKD), familial dysautonomia, hypertrophic scars, and NAFLD (Nonalcoholic Fatty Liver Disease) are some of the major factors expected to drive revenue growth of the global tocotrienol market.

Tocotrienols are a group of vitamin E equivalents that modulate several mechanisms in our body. Tocotrienols involve a group of unsaturated forms of vitamin E termed alpha, gamma, beta, and delta.

Some Key Findings From the Report:

  • Among the form segments, the alpha tocotrienol segment accounted for the largest revenue share of 34.5% in the global tocotrienol market in 2020. Alpha tocotrienol is naturally found in cereals and vegetables such as rice bran oil, palm oil, coconut oil, wheat germ, barley germ, and annatto.
  • North America market accounted for the largest revenue share in the global tocotrienol market in 2020, and is expected to continue with its dominance over the forecast period, owing to rising applications of tocotrienol in dietary supplements & pharmaceuticals and increasing demand for naturally sourced pharmaceuticals in the region.
  • The Asia Pacific market size was USD 88.6 Million in 2020, due to increasing consumption of healthy foods and supplements among health conscious individuals in countries in the region.
  • Key players profiled in the report include BASF SE, BTSA (Biotechnologías Aplicados SA), American River Nutrition Inc., Eisai Food & Chemical Co. Ltd., Vance Group Ltd., ExcelVite Inc., Davos Life Science Ltd., SourceOne Global Partners, Orochem Technologies Inc., Sime Darby Bioganic Sdn. Bhd. The market players have adopted various strategies including mergers, acquisitions, partnerships, and new product developments, among other strategies, to stay ahead of the competition and expand market footprint.

For the purpose of this report, the global tocotrienol market is segmented on the basis of form, application, end use, and region:


Form Outlook (Revenue, USD Million; 2018 - 2028)

  • Alpha tocotrienol
  • Beta tocotrienol
  • Gamma tocotrienol
  • Delta tocotrienol

Application Outlook (Revenue, USD Million; 2018 - 2028)

  • Breast cancer
  • Chronic kidney disease or CKD
  • Familial dysautonomia
  • Hypertrophic scars

- NAFLD (Nonalcoholic fatty liver disease)

  • Others

End Use Outlook (Revenue, USD Million; 2018 - 2028)

  • Dietary supplements
  • Pharmaceuticals
  • Cosmetics
  • Others

Region Outlook (Revenue, USD Million; 2018 - 2028)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Benelux
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa

Reasons to Buy the Report

  • A robust analysis and estimation of the Tocotrienol Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
  • A holistic competitive landscape of the all the major players in the Tocotrienol Market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
  • Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
  • Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
  • Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization

Table of Contents

Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2018 - 2026
Chapter 3. Indicative Metrics
3.1. Rising prevalence of target diseases
Chapter 4. Tocotrienols Segmentation & Impact Analysis
4.1. Tocotrienols Segmentation Analysis
4.2. Tocotrienols Market Value Chain Analysis, 2016-2026
4.3. Regulatory framework
4.4. Tocotrienols Market Impact Analysis
4.4.1. Market driver analysis
4.4.1.1. Rapid growth in emerging economies
4.4.1.2. Rising applications of tocotrienols in dietary supplements & pharmaceuticals
4.4.1.3. Demand for naturally sourced pharmaceuticals
4.4.2. Market restraint analysis
4.4.2.1. Lack of research on side-effects
4.5. Key opportunities prioritized
4.6. Industry analysis - Porter's
4.7. Tocotrienols PESTEL Analysis
Chapter 5. Tocotrienols Market By Form Insights & Trends
5.1. Tocotrienols Form dynamics & Market Share, 2018 & 2026
5.2. Alpha tocotrienol
5.2.1. Market estimates and forecast, 2016 - 2026 (USD Million)
5.2.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
5.3. Beta tocotrienol
5.3.1. Market estimates and forecast, 2016 - 2026 (USD Million)
5.3.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
5.4. Gamma tocotrienol
5.4.1. Market estimates and forecast, 2016 - 2026 (USD Million)
5.4.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
5.5. Delta tocotrienol
5.5.1. Market estimates and forecast, 2016 - 2026 (USD Million)
5.5.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
Chapter 6. Tocotrienols Market By Applications Insights & Trends
6.1. Tocotrienols Applications dynamics & Market Share, 2018 & 2026
6.2. Breast cancer
6.2.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.2.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
6.3. Chronic kidney disease or CKD
6.3.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.3.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
6.4. Familial dysautonomia
6.4.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.4.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
6.5. Hypertrophic scars
6.5.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.5.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
6.6. NAFLD
6.6.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.6.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
6.7. Others
6.7.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.7.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
Chapter 7. Tocotrienols Market By End Use Insights & Trends
7.1. Tocotrienols End Use dynamics & Market Share, 2018 & 2026
7.2. Dietary supplement
7.2.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.2.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.3. Pharmaceuticals
7.3.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.3.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.4. Cosmetics
7.4.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.4.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.5. Others
7.5.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.5.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
Chapter 8. Tocotrienols Market Regional Outlook
8.1. Tocotrienols Market share by region, 2018 & 2026
8.2. North America
8.2.1. North America Tocotrienols Market estimates and forecast, 2016 - 2026, (USD Million)
8.2.2. North America Tocotrienols Market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.2.3. North America Tocotrienols Market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.2.4. North America Tocotrienols Market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.2.5. U.S.
8.2.5.1. U.S. Tocotrienols Market estimates and forecast, 2016 - 2026, (USD Million)
8.2.5.2. U.S. Tocotrienols Market estimates and forecast by Form 2016 - 2026, (USD Million)
8.2.5.3. U.S. Tocotrienols Market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.2.5.4. U.S. Tocotrienols Market estimates and forecast by End use, 2016 - 2026, (USD Million)
8.2.6. Canada
8.2.6.1. Canada Tocotrienols Market estimates and forecast, 2016 - 2026, (USD Million)
8.2.6.2. Canada Tocotrienols Market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.2.6.3. Canada Tocotrienols Market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.2.6.4. Canada Tocotrienols Market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.2.7. Mexico
8.2.7.1. Mexico Tocotrienols Market estimates and forecast, 2016 - 2026, (USD Million)
8.2.7.2. Mexico Tocotrienols Market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.2.7.3. Mexico Tocotrienols Market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.2.7.4. Mexico Tocotrienols Market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.3. Europe
8.3.1. Europe Tocotrienols Market estimates and forecast, 2016 - 2026, (USD Million)
8.3.2. Europe Tocotrienols Market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.3.3. Europe Tocotrienols Market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.3.4. Europe Tocotrienols Market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.3.5. Germany
8.3.5.1. Germany Tocotrienols Market estimates and forecast, 2016 - 2026, (USD Million)
8.3.5.2. Germany Tocotrienols Market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.3.5.3. Germany Tocotrienols market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.3.5.4. Germany Tocotrienols market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.3.6. France
8.3.6.1. France Tocotrienols Market estimates and forecast, 2016 - 2026, (USD Million)
8.3.6.2. France Tocotrienols Market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.3.6.3. France Tocotrienols market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.3.6.4. France Tocotrienols market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.3.7. U.K.
8.3.7.1. U.K Tocotrienols market estimates and forecast, 2016 - 2026, (USD Million)
8.3.7.2. U.K Tocotrienols market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.3.7.3. U.K. Tocotrienols market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.3.7.4. U.K. Tocotrienols market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.3.8. Spain
8.3.8.1. Spain Tocotrienols market estimates and forecast, 2016 - 2026, (USD Million)
8.3.8.2. Spain Tocotrienols market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.3.8.3. Spain. Tocotrienols market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.3.8.4. Spain Tocotrienols market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.3.9. Italy
8.3.9.1. Italy Tocotrienols Market estimates and forecast, 2016 - 2026, (USD Million)
8.3.9.2. Italy Tocotrienols Market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.3.9.3. Italy Tocotrienols market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.3.9.4. Italy Tocotrienols market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.3.10. Rest of Europe
8.3.10.1. Rest of Europe Tocotrienols market estimates and forecast, 2016 - 2026, (USD Million)
8.3.10.2. Rest of Europe Tocotrienols market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.3.10.3. Rest of Europe Tocotrienols market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.3.10.4. Rest of Europe Tocotrienols market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Tocotrienols market estimates and forecast, 2016 - 2026, (USD Million)
8.4.2. Asia Pacific Tocotrienols market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.4.3. Asia Pacific Tocotrienols market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.4.4. Asia Pacific Tocotrienols market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.4.5. China
8.4.5.1. China Tocotrienols market estimates and forecast, 2016 - 2026, (USD Million)
8.4.5.2. China Tocotrienols market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.4.5.3. China Tocotrienols market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.4.5.4. China Tocotrienols market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.4.6. Japan
8.4.6.1. Japan Tocotrienols market estimates and forecast, 2016 - 2026, (USD Million)
8.4.6.2. Japan Tocotrienols market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.4.6.3. Japan Tocotrienols market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.4.6.4. Japan Tocotrienols market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.4.7. India
8.4.7.1. India Tocotrienols market estimates and forecast, 2016 - 2026, (USD Million)
8.4.7.2. India Tocotrienols market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.4.7.3. India Tocotrienols market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.4.7.4. India Tocotrienols market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.4.8. South Korea
8.4.8.1. South Korea Tocotrienols Market estimates and forecast, 2016 - 2026, (USD Million)
8.4.8.2. South Korea Tocotrienols Market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.4.8.3. South Korea Tocotrienols Market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.4.8.4. South Korea Tocotrienols Market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.4.9. Australia
8.4.9.1. Australia Tocotrienols Market estimates and forecast, 2016 - 2026, (USD Million)
8.4.9.2. Australia Tocotrienols Market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.4.9.3. Australia Tocotrienols Market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.4.9.4. Australia Tocotrienols Market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.4.10. Rest of Asia Pacific
8.4.10.1. Rest of Asia Pacific Tocotrienols market estimates and forecast, 2016 - 2026, (USD Million)
8.4.10.2. Rest of Asia Pacific Tocotrienols market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.4.10.3. Rest of Asia Pacific Tocotrienols market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.4.10.4. Rest of Asia Pacific Tocotrienols market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.5. Middle East & Africa
8.5.1. Middle East and Africa Tocotrienols market estimates and forecast, 2016 - 2026, (USD Million)
8.5.2. Middle East and Africa Tocotrienols market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.5.3. Middle East and Africa Tocotrienols market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.5.4. Middle East and Africa Tocotrienols market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.5.5. South Africa
8.5.5.1. South Africa Tocotrienols market estimates and forecast, 2016 - 2026, (USD Million)
8.5.5.2. South Africa Tocotrienols market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.5.5.3. South Africa Tocotrienols market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.5.5.4. South Africa Tocotrienols market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.5.6. Rest of Middle East and Africa
8.5.6.1. Rest of Middle East and Africa Tocotrienols market estimates and forecast, 2016 - 2026, (USD Million)
8.5.6.2. Rest of Middle East and Africa Tocotrienols market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.5.6.3. Rest of Middle East and Africa Tocotrienols market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.5.6.4. Rest of Middle East and Africa Tocotrienols market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.6. Latin America
8.6.1. Latin America Tocotrienols market estimates and forecast, 2016 - 2026, (USD Million)
8.6.2. Latin America Tocotrienols market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.6.3. Latin America Tocotrienols market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.6.4. Latin America Tocotrienols market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.6.5. Brazil
8.6.5.1. Brazil Tocotrienols market estimates and forecast, 2016 - 2026, (USD Million)
8.6.5.2. Brazil Tocotrienols market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.6.5.3. Brazil Tocotrienols market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.6.5.4. Brazil Tocotrienols market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.6.6. Argentina
8.6.6.1. Argentina Tocotrienols Market estimates and forecast, 2016 - 2026, (USD Million)
8.6.6.2. Argentina Tocotrienols Market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.6.6.3. Argentina Tocotrienols Market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.6.6.4. Argentina Tocotrienols Market estimates and forecast by End Use, 2016 - 2026, (USD Million)
8.6.7. Rest of Latin America
8.6.7.1. Rest of Latin America Tocotrienols Market estimates and forecast, 2016 - 2026, (USD Million)
8.6.7.2. Rest of Latin America Tocotrienols Market estimates and forecast by Form, 2016 - 2026, (USD Million)
8.6.7.3. Rest of Latin America Tocotrienols Market estimates and forecast by Applications, 2016 - 2026, (USD Million)
8.6.7.4. Rest of Latin America Tocotrienols Market estimates and forecast by End Use, 2016 - 2026, (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Revenue Share by Manufacturers
9.2. Manufacturing Cost Breakdown Analysis
9.3. Mergers & Acquisitions
9.4. Strategy Benchmarking
9.5. Vendor Landscape
Chapter 10. Company Profiles
10.1. BASF
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Length Benchmarking
10.1.4. Strategic Initiatives
10.2. BTSA Biotechnologías Aplicados SA
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Length Benchmarking
10.2.4. Strategic Initiatives
10.3. American River Nutrition, Inc.
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Length Benchmarking
10.3.4. Strategic Initiatives
10.4. Eisai Food & Chemical Co.Ltd.
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Length Benchmarking
10.4.4. Strategic Initiatives
10.5. Vance Group Ltd.
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Length Benchmarking
10.5.4. Strategic Initiatives
10.6. ExcelVite Inc.
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Length Benchmarking
10.6.4. Strategic Initiatives
10.7. Davos Life Science Ltd.
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Length Benchmarking
10.7.4. Strategic Initiatives
10.8. SourceOne
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Length Benchmarking
10.8.4. Strategic Initiatives
10.9. Orochem
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Length Benchmarking
10.9.4. Strategic Initiatives
10.10. Sime Darby Bioganic Sdn. Bhd
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Length Benchmarking
10.10.4. Strategic Initiatives

Companies Mentioned

  • BASF
  • ExcelVite Inc.
  • BTSA Biotechnologías Aplicados SA
  • Eisai Food & Chemical Co.Ltd.
  • Vance Group Ltd
  • American River Nutrition Inc. Davos Life Science Ltd.
  • SourceOne
  • Orochem
  • Sime Darby Bioganic Sdn.